Skip to main content
. 2017 Oct 11;24(1):1549–1564. doi: 10.1080/10717544.2017.1386729

Figure 9.

Figure 9.

In vivo anticancer activity of GE11-Ori-Se NPs in xenograft KYSE-150 cancer nude mice. (A) Images of the tumor from control and GE11-Ori-Se NPs treated xenograft KYSE-150 cancer nude mice. (B) Effects of GE11-Ori-Se NPs on tumor weight, n = 6, ***p < .001. (C) Body weight of xenograft KYSE-150 cancer nude mice treated by GE11-Ori-Se NPs, n = 6. The data was obtained at the last day of experiment before the sacrifice of mice. Effects of GE11-Ori-Se NPs on the serum (D) TNF-α and (E) IL-2 level in xenograft KYSE-150 cancer nude mice, n = 3, *p < .05, **p < .01, ***p < .001. (F) Quantitative analysis of Se contents in different organs in control and GE11-Ori-Se NPs treated mice, n = 3.